Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Biome Australia Ltd ( (AU:BIO) ) has issued an announcement.
Biome Australia Limited reported record quarterly sales revenue of $5.94 million for Q1 FY26, surpassing its forecast by 8% and marking a 40% increase from the previous year. This growth highlights Biome’s strong market position and product demand, positioning the company on track to achieve its Vision 27 revenue guidance of at least $75 million.
The most recent analyst rating on (AU:BIO) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Biome Australia Ltd stock, see the AU:BIO Stock Forecast page.
More about Biome Australia Ltd
Biome Australia Limited operates in the microbiome health industry, focusing on products such as Activated Probiotics. The company targets the practitioner-only category within pharmacies, where it has seen significant growth and increased shelf space.
Average Trading Volume: 401,891
Technical Sentiment Signal: Sell
Learn more about BIO stock on TipRanks’ Stock Analysis page.